Valsartan clinical trials angiotensin-receptor blockers

Aventis brand of valsartan - Nisis - CGP 48933 - walsartan - Vals - Provas - KalpressMiten - Tareg - Diovan - valsartan

Acute myocardial infarction

2 trials  - VALIANT (valsartan alone) - VALIANT (valsartan+capropril)

Atrial fibrillation

Patient with history of atrial fibrillation:  1 trials  - GISSI-AF (Disertori)

Patients without history of AF (primary prevention):  1 trials  - Val-HeFT (AF ancillary study)

Diabetes type 2

All type of patients :  1 trials  - NAVIGATOR valsartan

People with impaired glucose tolerance:  1 trials  - NAVIGATOR valsartan

Heart failure

All type of patients:  6 trials  - VALIDD - HEAVEN - Val-HeFT - V-HeFT - Mazayev et al. (vs lisinopril - Mazayev et al. (vs placebo)

Patients already receiving ACE inhibitor:  3 trials  - HEAVEN - Val-HeFT - V-HeFT

Patients previously untreated with ACE inhibitors:  2 trials  - Mazayev et al. (vs lisinopril - Mazayev et al. (vs placebo)

Patients with preserved-LVEF heart failure :  1 trials  - VALIDD

Hypertension

1 trials  - VALIANT/Val

Impaired fasting glucose

1 trials  - NAVIGATOR valsartan

Miscellaneous

Patients at high risk for cardiovascular events